Home > Back to Publisher > Report Information

Japan Generics Market Analysis

RNCOS
February 1, 2012
55 Pages - SKU: CICQ6800354

Abstract Table of Contents Related Reports

Countries covered: Japan

Japan is the world's second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare expenses and high mortality rates, the government has now been playing a vital role in promoting generics. The patent expiry of branded drugs and active ingredients will also act as a strong growth driver for the market in future. According to the findings of our latest report, the generics market in Japan stood at around US$ 9 Billion in 2010. It estimates that the growth in generic drugs will outshine the expansion in overall pharmaceutical market.

According to "Japan Generics Market Analysis", Japan is expected to be the next generic hub, and cancer related generics exhibit vast potential. The report finds out how vital is the role of National Health Insurance (NHI) pharmacies and Diagnosis Procedure Combination (DPC) hospitals in the industry development. It was observed that the DPC hospitals, in particular, have been growing at a robust rate, promoting generics penetration. We also found that ethical generics hold the majority share in the generic drugs market.

A detailed demographic analysis was carried out in the research that revealed that the population aged 65 years and above accounts for maximum healthcare-related expenditures in Japan, and hence becomes the target population for generics promotion. Further, a meticulous disease and age-wise segmentation has provided the holistic understanding of the healthcare-related demand parameters prevailing in the country.

The government in Japan has taken several initiatives to ensure growth and promotion of generics industry in the country. Recently, special premium-based incentives have been given to pharmacists on generic promotion. In near future, the government plans to bring in more reforms in medical care system. Our research talks about such revisions and reforms briefly to present a balanced outlook of the industry to clients. Analysis of current trends, profiles of key players in the Japanese generic market, and recent developments in the industry have also been included in the comprehensive study.

1. Analyst View
2. Research Methodology
3. Recent Market Trends: 3.1 NHI Pharmacies and DPC Hospitals to Contribute Majorly in Generics; 3.2 Japan: Next Generic Hub for Pharma Majors; 3.3 Cancer Generics Projected for Exorbitant Growth
4. Demographics Profile
5. The Japanese Pharmaceutical Market Outlook to 2014
6. The Japanese Generic Drugs Market Overview: 6.1 Healthcare Expenditure; 6.2 Generics Penetration; 6.3 Generics Market Outlook to 2014; 6.4 Ethical vs OTC Generics; 6.5 Distribution System; 6.6 Recent Generic Launches
7. Consumer Behavior Analysis: 7.1 Patients View; 7.2 Physicians and Pharmacist View
8. Regulatory Environment: 8.1 Role of MHLW; 8.2 Key Requirements for Generics Approval and Marketing Authorization; 8.3 Patent System
9. Key Government Initiatives
10. Opportunity Assessment: 10.1 By Patent Expiration; 10.2 By Therapeutic Treatment
11. Key Players: 11.1 Nichi-Iko; 11.2 Sawai Pharmaceuticals; 11.3 Taiyo Pharmaceutical; 11.4 Towa; 11.5 Meiji Seika; 11.6 Nippon Chemipher
List of Figures:: Figure 3-1: Cancer Mortality Rate (per 100,000 Population), 2000 & 2010; Figure 5-1: Pharmaceutical Market (Billion US$), 2010-2014; Figure 5-2: Share of Generics in Pharmaceutical Market (2011); Figure 5-3: Pharmaceutical Sales by Facility (%), 2009; Figure 6-1: Healthcare Expenditure (Billion US$), 2010 & 2015; Figure 6-2: Percentage Distribution of Healthcare Expenditure by Diseases for Population Aged below 65 (2008); Figure 6-3: Percentage Distribution of Healthcare Expenditure by Diseases for Population Aged 65 and Above (2008); Figure 6-4: Share of Generic Drugs in Pharmaceuticals Market w.r.t Developed Countries (2009); Figure 6-5: Generic Drugs Market (Billion US$), 2010-2014; Figure 6-6: Market Share of Generic Drugs Manufacturers (2010); Figure 6-7: Generic Drugs Market by Segment (%), 2009; Figure 6-8: Generic Drugs Market by Medical Institution (%), 2008 & 2009; Figure 6-9: Number of DPC Hospitals (FY 2007 to FY 2010); Figure 6-10: Generic Drugs Market by Distribution Channel (%), 2008 & 2009; Figure 11-1: Sawai Pharmaceutical - Sales by Therapeutic Category (%), FY 2010; Figure 11-2: Towa Pharmaceutical - Sales by Therapeutic Category (%), Mar 2011
List of Tables:: Table 3-1: Recent Industry Activities in Cancer Generics; Table 4-1: Demographic Characteristics (2010 & 2015); Table 6-1: Recent Generic Drugs Launch of Key Players (2011); Table 8-1: Application Fee for Manufacturing and Marketing of Generics (JPY); Table 9-1: Key Measures for Generic Drugs Promotion; Table 10-1: Patent Expiry of Key Drugs in Japan (2012-2015)

More Japan Manufacturing, Packaging & Detailing Reports

Japan Pharma Market Intelligence by PharmaIntellect
Looking at the great deal of business interest in the Japan Pharmaceutical space, we have recently published a report - "Japan Pharma – Market ...

Freedonia Focus on Pharmaceutical Packaging: Japan by Freedonia Focus
This report discusses pharmaceutical packaging in Japan for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; market overview; ...

Japan Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International

The Pharmaceutical Market: Japan (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

Pharmaceutical Packaging - Japan by Global Research & Data Services
This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for pharmaceutical packaging in Japan. The analysis provides ...

See all reports like this >>

More Japan Reports

D&B Country Report: Japan by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Plimsoll Portfolio Analysis - Guard Services (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Guard Services is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Plimsoll Portfolio Analysis - Business Consultants (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Business Consultants is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Plimsoll Portfolio Analysis - Land Developers (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Land Developers is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Japan: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis of Japan, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

See all reports like this >>

Japan Generics Market Analysis

Share this report

Other tasks

Research Assistance

Related Markets

Manufacturing, Packaging & Detailing Reports

Free Alert Me service